We could not find any results for:
Make sure your spelling is correct or try broadening your search.
By Colin Kellaher U.S.-listed shares of Kazia Therapeutics jumped in premarket trading Thursday after the Australian biotechnology company said the U.S. Food and Drug Administration granted a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | -0.095 | -54.2857142857 | 0.175 | 0.185 | 0.051 | 306008 | 0.09921602 | DE |
156 | -1.19 | -93.7007874016 | 1.27 | 1.65 | 0.051 | 171635 | 0.33207345 | DE |
260 | -0.33 | -80.487804878 | 0.41 | 1.88 | 0.051 | 190137 | 0.63778277 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions